This is a condition where bones become weak and brittle, making them more likely to break. It often happens in women after they go through menopause, due to a lack of estrogen. This loss of bone density can lead to fractures, especially in the hip, spine, and wrists.
Every report comes from a Lived member, sent anonymously.
Have you tried Fosamax (Alendronate) for Postmenopausal Osteoporosis?
Postmenopausal osteoporosis is a loss of bone strength that develops after menopause, leaving bones thin and fragile enough to break from a minor fall or bump that would not hurt healthy bone. The hip, the spine and the wrist are the bones most often affected. Osteoporosis is often called silent because it usually causes no symptoms until a bone breaks. A broken bone in the spine (a vertebra) can cause sudden back pain, but many spine fractures go unnoticed and show up only as lost height or a forward-curving upper back. The stakes are real: about half of white women in the US aged 50 and older will break a bone because of osteoporosis, and many people never fully regain their previous independence after a hip fracture.
Bone is living tissue that the body constantly breaks down and rebuilds. Estrogen helps keep those two processes in balance, so when estrogen falls at menopause, breakdown outpaces rebuilding. Bone density drops by about 2% a year for roughly the first decade after menopause, and the spine, which is rich in the spongy inner bone that turns over fastest, tends to lose strength first. Not everyone who goes through menopause develops osteoporosis. Risk is higher with older age, a slim or small frame, a parent who had osteoporosis or broke a hip, early menopause, and white or Asian ancestry. Smoking, heavy drinking, inactivity and a diet low in calcium, vitamin D or protein add to it. Some medicines contribute, especially corticosteroids such as prednisone taken for months or longer, as do conditions such as rheumatoid arthritis, eating disorders and some hormone and digestive disorders. These factors raise the odds rather than making a fracture inevitable, and an assessment also looks for causes of bone loss that can be treated directly.
Osteoporosis is usually diagnosed with a bone density scan called DXA (dual-energy X-ray absorptiometry), a quick, painless, low-radiation scan of the hip and lower spine. The result is reported as a T-score, which compares your bone density with that of a healthy young adult. A T-score of -1.0 or above is normal. A score between -1.0 and -2.5 means low bone mass, sometimes called osteopenia. A score of -2.5 or lower means osteoporosis. For example, a hip T-score of -2.8 meets the threshold, while -1.8 does not. The T-score is only part of the picture. Clinicians often combine it with FRAX (the Fracture Risk Assessment Tool), a calculator that estimates the chance of breaking a hip or another major bone over the next 10 years from age, past fractures, family history and other factors. In the US, treatment is generally advised for someone with low bone mass whose 10-year risk is at least 3% for a hip fracture or at least 20% for any major osteoporosis-related fracture. A hip or spine fracture from a minor fall is treated as osteoporosis whatever the scan shows. US screening guidance recommends a bone density test for all women 65 and older, and earlier for postmenopausal women with risk factors. Before treatment starts, blood and sometimes urine tests look for other causes of bone loss that need their own treatment, such as low vitamin D. A spine X-ray, or a spine image taken during the DXA scan, can find fractures that never caused symptoms.
Treatment aims to prevent fractures, not just to improve a number on a scan. Everyone benefits from the basics: enough calcium (about 1,200 mg a day for women over 50, ideally mostly from food) and vitamin D, regular weight-bearing and muscle-strengthening exercise, balance training, not smoking, limiting alcohol and removing fall hazards at home. For someone who already has osteoporosis, these habits support treatment but are rarely enough on their own. Most medicines are antiresorptives, which slow the cells that break bone down. The most widely used are bisphosphonates. Alendronate (Fosamax) is a weekly tablet that cuts spine and hip fractures by about half in women at high risk. It must be taken first thing in the morning on an empty stomach with a full glass of plain water, staying upright for at least 30 minutes, because it can irritate the esophagus. Zoledronic acid (Reclast) is a once-a-year IV infusion; the first dose often causes flu-like aches and fever, and later doses much less often. Denosumab (Prolia) is an injection every six months that reduces spine, hip and other fractures. Its effect wears off quickly: if doses are delayed or stopped without switching to another medicine, bone loss rebounds and several spine fractures can occur within months. Raloxifene (Evista), a daily pill that acts like estrogen on bone, lowers the risk of spine fractures; it can worsen hot flashes and raises the risk of blood clots, so it is not used by women who have had one. Bone-building (anabolic) medicines stimulate new bone and are often chosen first for people at very high risk, such as after a recent spine fracture, with several spine fractures or with a T-score of -3.5 or lower. Teriparatide (Forteo) and abaloparatide (Tymlos) are daily self-injections, usually given for up to two years. Romosozumab (Evenity) is given as monthly injections for one year; it carries a warning about heart attack and stroke and is not started within a year of either. Because their benefit fades once they stop, these medicines are always followed by an antiresorptive. Menopausal hormone therapy also prevents bone loss and can be a reasonable option for a younger postmenopausal woman, especially one who also has troublesome hot flashes, once its own risks are weighed. Bisphosphonates and denosumab rarely cause two serious problems: osteonecrosis of the jaw (an area of jawbone that fails to heal, usually after a tooth extraction or oral surgery) and an unusual break in the thigh bone. A dental check before starting and good oral hygiene lower the jaw risk, and the rarity of these problems is part of why guidelines review whether a bisphosphonate is still needed after several years. Kidney function, other health conditions, cost and whether you prefer a pill, an infusion or injections all shape the choice.
Osteoporosis is a long-term condition. Treatment lowers fracture risk substantially, but it does not cure the disease, and spine bones that have already collapsed cannot be restored. Even if a later scan improves, the diagnosis and the need for monitoring remain. Most osteoporosis medicines cause no noticeable change from day to day, so their benefit is preventive. A repeat DXA scan is usually done 1 to 2 years after starting or changing treatment. Because bisphosphonates stay in bone for years, people whose risk has fallen after about 5 years of tablets or 3 years of yearly infusions may take a planned break, often called a drug holiday, while monitoring continues. Denosumab and the bone-building medicines do not allow that kind of break; stopping them needs a planned handoff to another medicine. A fracture can change daily life considerably. Spine fractures can cause lasting back pain, height loss and a stooped posture, and physical therapy with back-strengthening exercise helps many people regain function and confidence. Hip fractures usually mean hospital care and a long recovery, and some people need ongoing help at home or in a care facility afterward. The first year or two after any fracture carries the highest risk of another, which is why starting or reviewing treatment soon after a fracture matters. Staying active, keeping muscles strong and reducing fall risks remain worthwhile at every stage.
Ask about a bone density test if you are 65 or older and have never had one, or sooner if you are postmenopausal and have risk factors such as a parent who broke a hip, early menopause, low body weight or long-term steroid use. Any broken bone after a fall from standing height or less is a reason to be checked for osteoporosis, even if the fall seemed like bad luck. Contact your care team if you notice sudden new back pain, a loss of height or a new stoop, which can signal a spine fracture. If you take a bisphosphonate or denosumab, call promptly about new, unexplained thigh, groin or hip pain, and report loose teeth, jaw pain or swelling, or exposed bone in the mouth. If a denosumab injection is overdue, or you want to stop it, contact your prescriber before the gap grows so a follow-up medicine can be planned. Back pain together with new leg weakness or numbness needs urgent medical assessment the same day. After a fall, hip or groin pain with an inability to stand or put weight on the leg can mean a broken hip: call 911.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with Postmenopausal Osteoporosis is like, what's helped you, or ask the community a question.